Episurf Medical AB

EPIS B

SE0003491562

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 12:00:01 2024-07-17 pm EDT			5-day change	1st Jan Change
0.221 ^SEK	-2.86%		+0.91%	-77.68%

Jul. 12	Episurf Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
Apr. 24	Episurf Medical Announces Distributor Agreement with Depuy-Synthes	CI

Episurf Medical AB Announces First Episealer Talus Surgery in the Asia-Pacific

January 11, 2021 at 05:15 am EST

Episurf Medical announces that the first surgery with the ankle implant Episealer® Talus in the Asia-Pacific region has been scheduled.

Latest news about Episurf Medical AB

Episurf Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	Jul. 12	CI
Episurf Medical Announces Distributor Agreement with Depuy-Synthes	Apr. 24	CI
Episurf Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Episurf Medical Plans SEK120 Million Rights Issue	Apr. 22	MT
Episurf Medical AB Elects Jess Lonner as New Member of the Board of Directors	Apr. 09	CI
Episurf Medical AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 09	CI
Sweden's Episurf Medical Secures New Patents in Asia, South Africa	Nov. 28	MT
Episurf Medical AB Receives Four Additional Patent Approval Notification	Nov. 28	CI
Episurf Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-27	CI
Episurf Medical Announces 510(k) Submission for Big Toe Implant	23-10-20	CI
Episurf Members Announces Nomination Committee for Episurf Medical's Annual General Meeting in 2024	23-10-17	CI
Episurf Medical Announces Early Clinical Results from Episealer Talus Study Presented at Scientific Congress	23-09-28	CI
Episurf Medical Announces Prospective Episealer Talus Clinical Study	23-09-13	CI
Episurf Medical's New Knee Joint Implant System Scheduled For Surgery Use in US	23-08-23	MT
Episurf Medical AB Announces First Commercial Case in the US Has Been Scheduled for Surgery	23-08-23	CI
Episurf Announces Results from the Use of Episealer Accepted for Publication in Scientific Journal	23-07-31	CI
Episurf Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-14	CI
Episurf Medical Wins Hospital Value Analysis Committee's Approval for Implant System	23-07-07	MT
Episurf Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Episurf Medical Builds US Distributor Network for Episealer Patellofemoral System	23-04-11	MT
Episurf Medical Receives Another Granted Patent in India	23-03-02	CI
Episurf Medical Receives Another Notice of Allowance from the United States Patent and Trademark Office	23-03-01	CI
Episurf Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-17	CI
Episurf Medical AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-17	CI
Episurf Medical AB Announces Dennis Stripe Not Stand for Re-Election as Chairman of the Board of Directors	23-02-13	CI

Episurf Medical AB is a Sweden-based medical technology company. It is engaged in the development, manufacture and marketing of implants and surgical drilling templates used in the treatment of local cartilage damage in knee joints. The Companyâs product portfolio includes the Episealer, and individually customized implant used as a cartilage replacement for early-stage patients; and Epiguide, a drill guide designed to attach to the kneeâs surface, as well as related surgical tools. The personalization of implants and instruments is based on magnetic resonance imaging (MRI) and enables less invasive treatment. The process of ordering and creation of patient-specific implants and surgical instruments is covered by software suite, microiFidelity, comprising microiClinic, microiDesign and microiManufacture. The main shareholder of the Company is Serendipity Ixora Fund AB.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-10-25 - Q3 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Episurf Medical AB

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
EPISURF MEDICAL AB	-77.68%	13.96M
STRYKER CORPORATION	+12.06%	127B
SMITH & NEPHEW PLC	+0.97%	12B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-18.47%	6.88B
GLAUKOS CORPORATION	+55.57%	6.86B
AXONICS, INC.	+9.34%	3.47B
ENOVIS CORPORATION	-15.42%	2.54B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-18.25%	1.9B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-27.00%	1.58B
DOUBLE MEDICAL TECHNOLOGY INC.	-37.52%	1.43B

Medical Devices & Implants